OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation
Tao Liu, Qinglv Wei, Jing Jin, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 7, pp. 3816-3831
Open Access | Times Cited: 556

Showing 1-25 of 556 citing articles:

The role of m6A modification in the biological functions and diseases
Xiulin Jiang, Baiyang Liu, Zhi Nie, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1244

Targeting the Wnt/β-catenin signaling pathway in cancer
Ya Zhang, Xin Wang
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 984

The potential role of RNA N6-methyladenosine in Cancer progression
Tianyi Wang, Shan Kong, Mei Tao, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 743

Roles of METTL3 in cancer: mechanisms and therapeutic targeting
Chengwu Zeng, Wanxu Huang, Yangqiu Li, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 390

The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities
Paz Nombela, Borja Miguel‐López, Sandra Blanco
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 332

m6A modification: recent advances, anticancer targeted drug discovery and beyond
Lijuan Deng, Wei-Qing Deng, Shu-Ran Fan, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 240

m6A-binding proteins: the emerging crucial performers in epigenetics
Yanchun Zhao, Yuanfei Shi, Huafei Shen, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 233

The m6A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function
Lifang Ma, Tianxiang Chen, Xiao Zhang, et al.
Redox Biology (2020) Vol. 38, pp. 101801-101801
Open Access | Times Cited: 190

RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent
Xin Wang, Linli Tian, Yushan Li, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 190

Insights into N6-methyladenosine and programmed cell death in cancer
Li Liu, Hui Li, Dingyu Hu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 160

Targeting the RNA m6A modification for cancer immunotherapy
Xinxin Li, Shoubao Ma, Youcai Deng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 139

Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis
Yinan Xiao, Meiyu Bi, Hongyan Guo, et al.
EBioMedicine (2022) Vol. 79, pp. 104001-104001
Open Access | Times Cited: 112

Targeting m6A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer
Yi Bao, Jianning Zhai, Huarong Chen, et al.
Gut (2023) Vol. 72, Iss. 8, pp. 1497-1509
Open Access | Times Cited: 112

Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine
Chen Xue, Qingfei Chu, Qiuxian Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 110

ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Sipei Nie, Lin Zhang, Jinhui Liu, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 109

YTHDF1 promotes breast cancer cell growth, DNA damage repair and chemoresistance
Yu Sun, Dan Dong, Yuhong Xia, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 86

RNA-binding proteins and cancer metastasis
Shengjie Wang, Zelong Sun, Zhe Lei, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 748-768
Closed Access | Times Cited: 85

YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner
Hengyu Chen, Yuanhang Yu, Ming Yang, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 75

Functions, mechanisms, and therapeutic implications of METTL14 in human cancer
Qian Guan, Huiran Lin, Lei Miao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 73

Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac4C acetylation of KIF23 mRNA
Chi Jin, Tuo Wang, Dongsheng Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 73

The RNA m6A writer WTAP in diseases: structure, roles, and mechanisms
Qibo Huang, Jie Mo, Zhibin Liao, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 66

Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation
Wanzun Lin, Li Chen, Haojiong Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 53

The RNA m6A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
Yun‐Guang Hong, Zhigang Yang, Yan Chen, et al.
Cancer Research (2023) Vol. 83, Iss. 6, pp. 845-860
Open Access | Times Cited: 47

m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion
Xiaoxue Cao, Qishun Geng, Danping Fan, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 46

Page 1 - Next Page

Scroll to top